Literature DB >> 27815612

Evaluation of dilution and normalization strategies to correct for urinary output in HPLC-HRTOFMS metabolomics.

Franziska C Vogl1, Sebastian Mehrl1, Leonhard Heizinger1, Inga Schlecht2, Helena U Zacharias1, Lisa Ellmann1, Nadine Nürnberger1, Wolfram Gronwald1, Michael F Leitzmann2, Jerome Rossert3, Kai-Uwe Eckardt4, Katja Dettmer1, Peter J Oefner5.   

Abstract

Reliable identification of features distinguishing biological groups of interest in urinary metabolite fingerprints requires the control of total metabolite abundance, which may vary significantly as the kidneys adjust the excretion of water and solutes to meet the homeostatic needs of the body. Failure to account for such variation may lead to misclassification and accumulation of missing data in case of less concentrated urine specimens. Here, different pre- and post-acquisition methods of normalization were compared systematically for their ability to recover features from liquid chromatography-mass spectrometry metabolite fingerprints of urine that allow distinction between patients with chronic kidney disease and healthy controls. Methods of normalization that were employed prior to analysis included dilution of urine specimens to either a fixed creatinine concentration or osmolality value. Post-acquisition normalization methods applied to chromatograms of 1:4 diluted urine specimens comprised normalization to creatinine, osmolality, and sum of all integrals. Dilution of urine specimens to a fixed creatinine concentration resulted not only in the least number of missing values, but it was also the only method allowing the unambiguous classification of urine specimens from healthy and diseased individuals. The robustness of classification could be confirmed for two independent patient cohorts of chronic kidney disease patients and yielded a shared set of 49 discriminant metabolite features. Graphical Abstract Dilution to a uniform creatinine concentration across urine specimens yields more comparable urinary metabolite fingerprints.

Entities:  

Keywords:  Creatinine; LC-MS; Metabolic fingerprinting; Normalization; Osmolality; Urine

Mesh:

Substances:

Year:  2016        PMID: 27815612     DOI: 10.1007/s00216-016-9974-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  10 in total

1.  Osmolality-based normalization enhances statistical discrimination of untargeted metabolomic urine analysis: results from a comparative study.

Authors:  Loïc Mervant; Marie Tremblay-Franco; Emilien L Jamin; Emmanuelle Kesse-Guyot; Pilar Galan; Jean-François Martin; Françoise Guéraud; Laurent Debrauwer
Journal:  Metabolomics       Date:  2021-01-02       Impact factor: 4.290

2.  Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.

Authors:  Mona M Khamis; Teagan Holt; Hanan Awad; Anas El-Aneed; Darryl J Adamko
Journal:  Metabolomics       Date:  2018-08-29       Impact factor: 4.290

3.  Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.

Authors:  Tyler Cook; Yinfa Ma; Sanjeewa Gamagedara
Journal:  J Pharm Biomed Anal       Date:  2019-09-03       Impact factor: 3.935

4.  Characterization of LC-MS based urine metabolomics in healthy children and adults.

Authors:  Xiaoyan Liu; Xiaoyi Tian; Shi Qinghong; Haidan Sun; Li Jing; Xiaoyue Tang; Zhengguang Guo; Ying Liu; Yan Wang; Jie Ma; Ren Na; Chengyan He; Wenqi Song; Wei Sun
Journal:  PeerJ       Date:  2022-06-22       Impact factor: 3.061

5.  Metabolite quantification: A fluorescence-based method for urine sample normalization prior to 1H-NMR analysis.

Authors:  James Gerard Wolfsberger; Emily C Hunt; Sai Sumedha Bobba; Sharifa Love-Rutledge; Bernhard Vogler
Journal:  Metabolomics       Date:  2022-10-19       Impact factor: 4.747

6.  Urinary metabolomics to develop predictors for pediatric acute kidney injury.

Authors:  Alexandra Franiek; Atul Sharma; Vedran Cockovski; David S Wishart; Michael Zappitelli; Tom D Blydt-Hansen
Journal:  Pediatr Nephrol       Date:  2022-01-10       Impact factor: 3.651

7.  Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy.

Authors:  Jessica Gooding; Lei Cao; Courtney Whitaker; Jean-Marie Mwiza; Mizpha Fernander; Faihaa Ahmed; Zach Acuff; Susan McRitchie; Susan Sumner; Elimelda Moige Ongeri
Journal:  BMC Nephrol       Date:  2019-04-25       Impact factor: 2.388

Review 8.  For what factors should we normalize urinary extracellular mRNA biomarkers?

Authors:  Pradeep Moon Gunasekaran; James Matthew Luther; James Brian Byrd
Journal:  Biomol Detect Quantif       Date:  2019-04-23

9.  Isotope Ratio Outlier Analysis (IROA) for HPLC-TOFMS-Based Metabolomics of Human Urine.

Authors:  Fadi Fadil; Claudia Samol; Raffaela S Berger; Fabian Kellermeier; Wolfram Gronwald; Peter J Oefner; Katja Dettmer
Journal:  Metabolites       Date:  2022-08-12

Review 10.  Chronic Kidney Disease Cohort Studies: A Guide to Metabolome Analyses.

Authors:  Ulla T Schultheiss; Robin Kosch; Fruzsina Kotsis; Michael Altenbuchinger; Helena U Zacharias
Journal:  Metabolites       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.